Hudbay Minerals Inc. Ordinary Shares (Canada) vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Hudbay Minerals Inc. Ordinary Shares (Canada) trades at $26.07 (market cap $11.24B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.59 (market cap $6.04B). The key difference: Hudbay Minerals Inc. Ordinary Shares (Canada) is the larger of the two by market cap, and Hudbay Minerals Inc. Ordinary Shares (Canada) pays a 0.11% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hudbay Minerals Inc. Ordinary Shares (Canada) for 1 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| HBM | IOVA | |
|---|---|---|
Market Cap | $11.24B | $6.04B |
Volume | 4,316,374 | 14,805,993 |
Sector | Basic Materials | Health |
52-Week High | $31.87 | $14.82 |
52-Week Low | $14.58 | $1.81 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $11.30B | $5.97B |
Dividend Yield | 0.11% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Hudbay Minerals is a mining company producing copper, gold, zinc, and other metals. Its operations are located in the Americas.
Read more on HBM →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →